688176 亚虹医药
已收盘 07-23 15:00:00
资讯
新帖
简况
亚虹医药获得发明专利授权:“嘧啶类化合物、其制备方法及其医药用途”
证券之星 · 07-21 19:02
亚虹医药获得发明专利授权:“嘧啶类化合物、其制备方法及其医药用途”
每周股票复盘:亚虹医药(688176)APL-1702上市申请获受理,股价涨幅达15%
证券之星 · 07-19
每周股票复盘:亚虹医药(688176)APL-1702上市申请获受理,股价涨幅达15%
亚虹医药拟使用剩余超募资金8704万元永久补充流动资金并增补董事
中访网数据 · 07-17
亚虹医药拟使用剩余超募资金8704万元永久补充流动资金并增补董事
亚虹医药:湘禾投资投资者于7月15日调研我司
证券之星 · 07-16
亚虹医药:湘禾投资投资者于7月15日调研我司
科创成长层改革推进 券商系统升级及风险揭示书签署有序展开
DoNews · 07-16
科创成长层改革推进 券商系统升级及风险揭示书签署有序展开
亚虹医药获得发明专利授权:“硝羟喹啉和其类似物与化学疗法和免疫疗法在癌症治疗中的组合用途”
证券之星企业动态 · 07-14
亚虹医药获得发明专利授权:“硝羟喹啉和其类似物与化学疗法和免疫疗法在癌症治疗中的组合用途”
7月14日亚虹医药(688176)龙虎榜数据:游资上海超短帮上榜
证券之星 · 07-14
7月14日亚虹医药(688176)龙虎榜数据:游资上海超短帮上榜
化学制药行业盘中拉升,亚虹医药-U等4只股票涨停
市场透视 · 07-14
化学制药行业盘中拉升,亚虹医药-U等4只股票涨停
肿瘤治疗概念盘中拉升,亚虹医药-U等2只股票涨停
市场透视 · 07-14
肿瘤治疗概念盘中拉升,亚虹医药-U等2只股票涨停
亚虹医药-U涨5.04%创近一年新高 创新管线驱动估值重构
智选洞察 · 07-14
亚虹医药-U涨5.04%创近一年新高 创新管线驱动估值重构
亚虹医药(688176)5623.45万股限售股将于7月7日解禁,占总股本9.87%
证券之星 · 07-07
亚虹医药(688176)5623.45万股限售股将于7月7日解禁,占总股本9.87%
每周股票复盘:亚虹医药(688176)召开2025年第一次临时股东大会
证券之星 · 07-05
每周股票复盘:亚虹医药(688176)召开2025年第一次临时股东大会
亚虹医药:将于2025年7月25日召开2025年第一次临时股东大会
公司公告 · 07-04
亚虹医药:将于2025年7月25日召开2025年第一次临时股东大会
亚虹医药:拟使用剩余超募资金8704.07万元用于永久补充流动资金
格隆汇资讯 · 06-27
亚虹医药:拟使用剩余超募资金8704.07万元用于永久补充流动资金
亚虹医药5623万限售股将于7月7日上市流通
财中社 · 06-27
亚虹医药5623万限售股将于7月7日上市流通
亚虹医药-U06月26日遭主力抛售150.5万元
市场透视 · 06-26
亚虹医药-U06月26日遭主力抛售150.5万元
亚虹医药入选2025中国化药研发实力榜TOP 100
亚虹医药 · 06-24
亚虹医药入选2025中国化药研发实力榜TOP 100
亚虹医药-U06月24日主力净流出349.0万元 散户资金买入
市场透视 · 06-24
亚虹医药-U06月24日主力净流出349.0万元 散户资金买入
亚虹医药-U06月23日主力净流入39.8万元 散户资金抛售
市场透视 · 06-23
亚虹医药-U06月23日主力净流入39.8万元 散户资金抛售
亚虹医药董事江新明辞任,徐瑛拟增补候选
财中社 · 06-20
亚虹医药董事江新明辞任,徐瑛拟增补候选
加载更多
公司概况
公司名称:
江苏亚虹医药科技股份有限公司
所属行业:
医药制造业
上市日期:
2022-01-07
主营业务:
江苏亚虹医药科技股份有限公司的主营业务是泌尿生殖系统肿瘤及女性健康领域医药的研发、生产和销售。公司的主要产品是抗肿瘤类产品、其他。
发行价格:
22.98
{"stockData":{"symbol":"688176","market":"SH","secType":"STK","nameCN":"亚虹医药","latestPrice":11.37,"timestamp":1753254000000,"preClose":11.61,"halted":0,"volume":15964389,"delay":0,"changeRate":-0.0207,"floatShares":434999999,"shares":570000000,"eps":-0.675,"marketStatus":"已收盘","change":-0.24,"latestTime":"07-23 15:00:00","open":11.46,"high":11.69,"low":11.35,"amount":183000000,"amplitude":0.0293,"askPrice":11.38,"askSize":154,"bidPrice":11.37,"bidSize":307,"shortable":0,"etf":0,"ttmEps":-0.675,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753320600000},"marketStatusCode":5,"adr":0,"adjPreClose":11.61,"symbolType":"stock_kcb","openAndCloseTimeList":[[1753234200000,1753241400000],[1753246800000,1753254000000]],"highLimit":12.77,"lowLimit":10.45,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":570000000,"isCdr":false,"pbRate":3.43,"roa":"--","roe":"--","epsLYR":-0.68,"committee":0.419383,"marketValue":6481000000,"turnoverRate":0.0367,"status":1,"afterMarket":{"amount":0,"volume":0,"close":11.37,"buyVolume":0,"sellVolume":0,"time":1753256038018,"indexStatus":"已收盘 07-23 15:30:00","preClose":11.61},"floatMarketCap":4940000000},"requestUrl":"/m/hq/s/688176","defaultTab":"news","newsList":[{"id":"2553011406","title":"亚虹医药获得发明专利授权:“嘧啶类化合物、其制备方法及其医药用途”","url":"https://stock-news.laohu8.com/highlight/detail?id=2553011406","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553011406?lang=zh_cn&edition=full","pubTime":"2025-07-22 03:02","pubTimestamp":1753124548,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示亚虹医药新获得一项发明专利授权,专利名为“嘧啶类化合物、其制备方法及其医药用途”,专利申请号为CN202310473956.2,授权日为2025年7月22日。今年以来亚虹医药新获得专利授权2个,较去年同期增加了100%。通过天眼查大数据分析,江苏亚虹医药科技股份有限公司共对外投资了3家企业,参与招投标项目2次;财产线索方面有商标信息123条,专利信息51条,著作权信息8条;此外企业还拥有行政许可18个。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072200002995.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK0239","BK1574","09939","688176","159938","BK1161"],"gpt_icon":0},{"id":"2552417377","title":"每周股票复盘:亚虹医药(688176)APL-1702上市申请获受理,股价涨幅达15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552417377","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552417377?lang=zh_cn&edition=full","pubTime":"2025-07-20 03:26","pubTimestamp":1752953171,"startTime":"0","endTime":"0","summary":"截至2025年7月18日收盘,亚虹医药报收于11.65元,较上周的9.93元上涨17.32%。本周,亚虹医药7月17日盘中最高价报11.96元,股价触及近一年最高点。此次是近5个交易日内第1次上榜。答:APL-1702上市申请获得受理,已完成关键上市策略制定和商业化路径规划。2025年第一季度实现营业收入6,110.11万元,同比增长151.24%。公司公告汇总江苏亚虹医药科技股份有限公司将于2025年7月25日10点在上海浦东新区高科西路551号万信酒店一楼会议室召开2025年第一次临时股东大会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072000000756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688176"],"gpt_icon":0},{"id":"2552176406","title":"亚虹医药拟使用剩余超募资金8704万元永久补充流动资金并增补董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2552176406","media":"中访网数据","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552176406?lang=zh_cn&edition=full","pubTime":"2025-07-17 08:10","pubTimestamp":1752711008,"startTime":"0","endTime":"0","summary":"中访网数据 江苏亚虹医药科技股份有限公司于2025年7月25日召开2025年第一次临时股东大会,审议两项关键议案。该金额占超募资金总额的28%,符合监管要求。公司承诺补充流动资金后12个月内不进行高风险投资或对外财务资助。背景信息: - 亚虹医药2021年IPO实际募资净额23.81亿元,超募资金3.11亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717081301954565d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717081301954565d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688176"],"gpt_icon":0},{"id":"2551444481","title":"亚虹医药:湘禾投资投资者于7月15日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2551444481","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551444481?lang=zh_cn&edition=full","pubTime":"2025-07-16 18:04","pubTimestamp":1752660264,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年7月16日亚虹医药发布公告称湘禾投资于2025年7月15日调研我司。APL-2302在以上肿瘤模型 中,单药或联合奥拉帕利抗肿瘤活性均优于 KSQ-4279,具 有成为同类最佳的潜力。APL-2302的临床前研究结果入选 2024年美国癌症研究协会年会,并以壁报形式公布。该临床研究已于 2025年 3月完成Ⅰ a期首例受试者 入组,公司将持续推进受试者入组工作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071600031009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688176","BK0239"],"gpt_icon":0},{"id":"2551119280","title":"科创成长层改革推进 券商系统升级及风险揭示书签署有序展开","url":"https://stock-news.laohu8.com/highlight/detail?id=2551119280","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551119280?lang=zh_cn&edition=full","pubTime":"2025-07-16 11:13","pubTimestamp":1752635582,"startTime":"0","endTime":"0","summary":"上交所方面正组织风险揭示书签署工作,并修订相关指南,新增《科创板科创成长层企业股票投资风险揭示书必备条款》,明确未盈利企业存在的各类投资风险。上交所下发通知要求券商完善适当性管理工作,包括完成风险揭示书签署及系统准备,给予投资者充分阅读时间,并通过多种渠道开展投资者教育。上交所将持续督促券商并开展监督检查。7月14日,上交所举办专题培训会,120家券商330余名相关负责人参会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071611164495444cb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071611164495444cb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688515","688256","688443","688220","688221","BK0239","688280","688316","688561","688176","688382","688373","000690.SH","688266","688512","688192","09969","688469","688538","01877","688322","02402","688702","688302","688387","688165","688327","688197","688343","688549","ONC","688277","06160"],"gpt_icon":0},{"id":"2551913364","title":"亚虹医药获得发明专利授权:“硝羟喹啉和其类似物与化学疗法和免疫疗法在癌症治疗中的组合用途”","url":"https://stock-news.laohu8.com/highlight/detail?id=2551913364","media":"证券之星企业动态","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551913364?lang=zh_cn&edition=full","pubTime":"2025-07-15 02:38","pubTimestamp":1752518296,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示亚虹医药新获得一项发明专利授权,专利名为“硝羟喹啉和其类似物与化学疗法和免疫疗法在癌症治疗中的组合用途”,专利申请号为CN201780032148.5,授权日为2025年7月15日。今年以来亚虹医药新获得专利授权1个,与去年同期持平。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071502394597a5ff54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071502394597a5ff54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688176"],"gpt_icon":0},{"id":"2551490154","title":"7月14日亚虹医药(688176)龙虎榜数据:游资上海超短帮上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2551490154","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551490154?lang=zh_cn&edition=full","pubTime":"2025-07-14 17:16","pubTimestamp":1752484590,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2025年7月14日公布的交易公开信息显示,亚虹医药因有价格涨跌幅限制的日收盘价格涨幅达到15%的前五只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年7月14日收盘,亚虹医药报收于11.65元,上涨17.32%,换手率14.45%,成交量62.8万手,成交额7.17亿元。从龙虎榜公布的当日买卖数据来看,机构合计净卖出2340.25万元。上海超短帮等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071400024642.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688176"],"gpt_icon":0},{"id":"2551297611","title":"化学制药行业盘中拉升,亚虹医药-U等4只股票涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2551297611","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551297611?lang=zh_cn&edition=full","pubTime":"2025-07-14 10:18","pubTimestamp":1752459494,"startTime":"0","endTime":"0","summary":"07月14日,化学制药行业盘中拉升,截至10点18分,化学制药行业整体指数上涨1.00%,报12992.350点。从个股上来看,该行业的成分股中,莱美药业、联环药业2只个股涨幅超过10%,亚虹医药-U等4只股票涨停,诚意药业、赛托生物等4只股涨幅超过5%。从资金上来看,截止发稿,化学制药行业主力净流入为-2.18亿,其中亚虹医药-U受到资金热捧,主力净流入6041.94万;拉长时间线来看,该板块近20日主力资金净流入-134.51亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071410181495417a73&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071410181495417a73&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688176"],"gpt_icon":0},{"id":"2551927029","title":"肿瘤治疗概念盘中拉升,亚虹医药-U等2只股票涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2551927029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551927029?lang=zh_cn&edition=full","pubTime":"2025-07-14 10:17","pubTimestamp":1752459467,"startTime":"0","endTime":"0","summary":"07月14日,肿瘤治疗概念盘中拉升,截至10点17分,肿瘤治疗概念整体指数上涨1.05%,报1594.390点。从个股上来看,该概念的成分股中,莱美药业涨幅超过10%,亚虹医药-U等2只股票涨停,海创药业-U、冠昊生物2只股涨幅超过5%。从资金上来看,截止发稿,肿瘤治疗概念主力净流入为-2.46亿,其中广生堂受到资金热捧,主力净流入5981.97万;拉长时间线来看,该板块近20日主力资金净流入-63.27亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071410174795417a4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071410174795417a4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688176","688302"],"gpt_icon":0},{"id":"2551592781","title":"亚虹医药-U涨5.04%创近一年新高 创新管线驱动估值重构","url":"https://stock-news.laohu8.com/highlight/detail?id=2551592781","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551592781?lang=zh_cn&edition=full","pubTime":"2025-07-14 09:34","pubTimestamp":1752456848,"startTime":"0","endTime":"0","summary":"亚虹医药-U今日股价显著攀升,截至09点33分,最新价报10.43元/股,涨幅达5.04%,突破10元整数关口并创近一年新高。资金博弈与政策预期共振亚虹医药-U近期股价波动主要受资金面切换及政策预期驱动。截至7月10日,主力资金连续两个交易日累计净流出超千万元,其中7月9日单日净流出占成交额12%,反映机构调仓动作。创新管线驱动估值重构公司长期价值取决于口服膀胱癌药物APL-1203的临床进展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714093707a6a77fc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714093707a6a77fc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688176"],"gpt_icon":0},{"id":"2549742713","title":"亚虹医药(688176)5623.45万股限售股将于7月7日解禁,占总股本9.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549742713","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549742713?lang=zh_cn&edition=full","pubTime":"2025-07-07 08:03","pubTimestamp":1751846586,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息整理,亚虹医药于7月7日将有5623.45万股限售股份解禁,为公司追加承诺限售股份上市流通,占公司总股本9.87%。最近一年内,该股累计解禁680.05万股,占总股本的1.19%。本次解禁后,公司还有1.35亿股限售股份,占总股本23.77%。亚虹医药主营业务:专注于泌尿生殖系统肿瘤及其它重大疾病领域,致力于为患者提供诊疗一体化解决方案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070700001544.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688176","BK0239"],"gpt_icon":0},{"id":"2549340916","title":"每周股票复盘:亚虹医药(688176)召开2025年第一次临时股东大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2549340916","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549340916?lang=zh_cn&edition=full","pubTime":"2025-07-06 06:28","pubTimestamp":1751754494,"startTime":"0","endTime":"0","summary":"截至2025年7月4日收盘,亚虹医药报收于9.59元,较上周的8.87元上涨8.12%。本周关注点公司公告汇总:亚虹医药将于2025年7月25日召开第一次临时股东大会,审议增补董事及使用剩余超募资金永久补充流动资金的议案公司公告汇总亚虹医药将于2025年7月25日10点召开2025年第一次临时股东大会,地点位于上海市浦东新区高科西路551号万信酒店一楼会议室。A股股东可通过现场投票或网络投票参与,网络投票时间为2025年7月25日的交易时间段。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070600000925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688176","BK0239"],"gpt_icon":0},{"id":"2548674563","title":"亚虹医药:将于2025年7月25日召开2025年第一次临时股东大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2548674563","media":"公司公告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548674563?lang=zh_cn&edition=full","pubTime":"2025-07-04 17:17","pubTimestamp":1751620620,"startTime":"0","endTime":"0","summary":"亚虹医药公告,将于2025年7月25日召开第一次临时股东大会,会议采用现场投票与网络投票相结合的方式。会议将审议《关于公司增补董事的议案》和《关于使用剩余超募资金永久补充流动资金的议案》。股权登记日为2025年7月21日,参会股东需在2025年7月22日前完成登记。会议地点位于上海市浦东新区高科西路551号万信酒店一楼会议室。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704173109a72e8e39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704173109a72e8e39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688176","BK0239"],"gpt_icon":0},{"id":"2546748193","title":"亚虹医药:拟使用剩余超募资金8704.07万元用于永久补充流动资金","url":"https://stock-news.laohu8.com/highlight/detail?id=2546748193","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546748193?lang=zh_cn&edition=full","pubTime":"2025-06-27 19:27","pubTimestamp":1751023671,"startTime":"0","endTime":"0","summary":"格隆汇6月27日丨亚虹医药(688176.SH)公布,公司超募资金总额为人民币31,072.76万元。本次拟使用剩余超募资金人民币8,704.07万元(含已到期利息收入及理财收益,实际金额以资金转出当日专户余额为准)用于永久补充流动资金。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062719280297914fa7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062719280297914fa7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688176","BK0239"],"gpt_icon":0},{"id":"2546710586","title":"亚虹医药5623万限售股将于7月7日上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2546710586","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546710586?lang=zh_cn&edition=full","pubTime":"2025-06-27 18:33","pubTimestamp":1751020380,"startTime":"0","endTime":"0","summary":"6月27日,亚虹医药发布公告,本次股票上市流通涉及5623万股首发限售股份,上市流通日期为2025年7月7日。此次上市流通的限售股主要来自公司首次公开发行前的部分股份,原锁定期为36个月,因股东对公司未来发展前景的信心,自愿延长锁定期6个月。这些股东均承诺在限售期内不转让或减持其持有的股份,且在上市后仍需遵守相关减持规定。2025年一季度,亚虹医药实现收入6110万元,归母净利润-8353万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/zqgd/2025-06-27/doc-infcphxe3761838.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688176","BK0239"],"gpt_icon":0},{"id":"2546834587","title":"亚虹医药-U06月26日遭主力抛售150.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546834587","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546834587?lang=zh_cn&edition=full","pubTime":"2025-06-26 15:21","pubTimestamp":1750922496,"startTime":"0","endTime":"0","summary":"06月26日, 亚虹医药-U股价跌1.66%,报收8.88元,成交金额7241.6万元,换手率2.15%,振幅2.44%,量比1.16。亚虹医药-U今日主力资金净流出150.5万元,连续3日净流出,上一交易日主力净流出13.1万元。|06月26日主力加仓幅度排名||#|股票简称|主力净额占比|#|欢瑞世纪|6.52%|#|华锋股份|6.02%|#|科创信息|5.98%|#|...|...|#2835|亚虹医药-U|-0.04%|亚虹医药-U所在的化学制药行业,今日主力净流出16.11亿元,行业排名7/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626171239a4bee3d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626171239a4bee3d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688176"],"gpt_icon":0},{"id":"2545407705","title":"亚虹医药入选2025中国化药研发实力榜TOP 100","url":"https://stock-news.laohu8.com/highlight/detail?id=2545407705","media":"亚虹医药","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545407705?lang=zh_cn&edition=full","pubTime":"2025-06-24 17:00","pubTimestamp":1750755622,"startTime":"0","endTime":"0","summary":"会上,《2025中国药品研发实力排行榜》系列榜单正式发布。亚虹医药凭借持续的科技创新和研发投入,成功入选《2025中国化药研发实力排行榜》TOP 100。截至目前,亚虹医药拥有12个产品、16个在研项目。作为一家专注于泌尿生殖系统肿瘤及女性健康领域的全球化创新药公司,此次入选“2025中国化药研发实力排行榜TOP 100”,是对亚虹医药创新实力与研发成果的高度认可。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624173047a4bb3499&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624173047a4bb3499&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688176"],"gpt_icon":0},{"id":"2545347402","title":"亚虹医药-U06月24日主力净流出349.0万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2545347402","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545347402?lang=zh_cn&edition=full","pubTime":"2025-06-24 15:20","pubTimestamp":1750749624,"startTime":"0","endTime":"0","summary":"06月24日,亚虹医药-U股价收平报9.06元,成交金额6405.0万元,换手率1.87%,振幅1.55%,量比0.73。亚虹医药-U今日主力资金净流出349.0万元,上一交易日主力净流入39.8万元。该股近5个交易日下跌0.33%,主力资金累计净流出3399.0万元;近20日主力资金累计净流出6770.9万元,其中净流出天数为13日。|06月24日主力加仓幅度排名||#|股票简称|主力净额占比|#|华铭智能|7.31%|#|星源卓镁|6.19%|#|信德新材|6.16%|#|...|...|#4205|亚虹医药-U|-0.10%|亚虹医药-U所在的化学制药行业,今日主力净流入5746万元,行业排名55/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624165508a4bb22ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624165508a4bb22ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688176","BK0239"],"gpt_icon":0},{"id":"2545561491","title":"亚虹医药-U06月23日主力净流入39.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2545561491","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545561491?lang=zh_cn&edition=full","pubTime":"2025-06-23 15:20","pubTimestamp":1750663220,"startTime":"0","endTime":"0","summary":"06月23日, 亚虹医药-U股价涨2.95%,报收9.06元,成交金额7491.8万元,换手率2.22%,振幅4.89%,量比0.79。亚虹医药-U今日主力资金净流入39.8万元,上一交易日主力净流出859.1万元。该股近5个交易日下跌4.43%,主力资金累计净流出6389.4万元;近20日主力资金累计净流出6954.4万元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623164831a7186075&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623164831a7186075&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688176","BK0239"],"gpt_icon":0},{"id":"2544147230","title":"亚虹医药董事江新明辞任,徐瑛拟增补候选","url":"https://stock-news.laohu8.com/highlight/detail?id=2544147230","media":"财中社","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544147230?lang=zh_cn&edition=full","pubTime":"2025-06-20 17:01","pubTimestamp":1750410084,"startTime":"0","endTime":"0","summary":"亚虹医药发布公告,董事江新明因工作调整辞去董事及董事会审计委员会委员职务,辞任时间为2025年6月20日。截至公告披露日,江新明通过泰州东虹企业管理中心间接持有公司约90万股股份,占总股本的0.16%。为应对董事会成员变动,公司于2025年6月20日召开会议,决定增补徐瑛为董事候选人,并同意其担任审计委员会委员。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620171908a4b44c4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620171908a4b44c4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688176","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753267982860,"stockEarnings":[{"period":"1week","weight":0.0338},{"period":"1month","weight":0.3193},{"period":"3month","weight":0.3971},{"period":"6month","weight":0.7485},{"period":"1year","weight":1.2072},{"period":"ytd","weight":0.7099}],"compareEarnings":[{"period":"1week","weight":0.0219},{"period":"1month","weight":0.0661},{"period":"3month","weight":0.0866},{"period":"6month","weight":0.1089},{"period":"1year","weight":0.2084},{"period":"ytd","weight":0.0686}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏亚虹医药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"24940人(较上一季度减少4.29%)","perCapita":"17422股","listingDate":"2022-01-07","address":"江苏省泰州市海陵区药城大道一号(创业路东侧、园南路北侧)的新药创制基地二期D幢大楼1009房间","registeredCapital":"57000万元","survey":" 江苏亚虹医药科技股份有限公司的主营业务是泌尿生殖系统肿瘤及女性健康领域医药的研发、生产和销售。公司的主要产品是抗肿瘤类产品、其他。","listedPrice":22.98},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"亚虹医药(688176)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供亚虹医药(688176)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"亚虹医药,688176,亚虹医药股票,亚虹医药股票老虎,亚虹医药股票老虎国际,亚虹医药行情,亚虹医药股票行情,亚虹医药股价,亚虹医药股市,亚虹医药股票价格,亚虹医药股票交易,亚虹医药股票购买,亚虹医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"亚虹医药(688176)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供亚虹医药(688176)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}